South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

转化候选者 我们建议开发一种基于多能干细胞 (PSC) 衍生的软骨球的通用、现成的关节软骨修复疗法 影响范围 该疗法可以治疗超过 10% 的人存在的主要软骨病变50岁以下； 这通常会导致疼痛和 ...

CIRM is governed by 35 dedicated Californians representing patients, researchers and the biotechnology industry whose knowledge, passion and commitment to CIRM’s mission has guided the organization ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

The last thing Maria Torres expected was to be diagnosed with type 2 diabetes. She exercised, ate well and kept her weight under control. There had to be some mistake. Maria asked her doctor to repeat ...

Las reuniones de la CFAOC están organizadas por la Oficina del Contralor del Estado. A continuación, se incluye una copia de la agenda publicada en https://www.sco ...

一种由抑制性神经元组成的细胞治疗产品，可以在脑外伤后迁移、整合和恢复神经功能。 近 6 万美国人（包括 700,000 万加州人）因脑外伤而患有永久性的身体或心理健康问题，但目前尚无治疗 ...

CIRM Staff Recommendation: Fund overall genomics center together with the associated Data Coordination and Management component. Furthermore, staff recommends removal of Center Initiated Project #3, ...

If you would like to contact CIRM regarding questions you may have about employment opportunities, please contact us at jobs@cirm.ca.gov. CIRM encourages job seekers to apply for specific job openings ...

San Francisco, CA – California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM) today approved $150 million in new funding to help move promising stem cell-based therapies ...

CIRM publishes Form 700s for all board members and executive staff on a yearly basis.

The Governing Board of the California Institute for Regenerative Medicine, the State Stem Cell Agency, approved a $25 million award to support the first FDA-approved clinical trial based on cells ...